Gynecology

Vaginal microbiota may be linked to increased Chlamydia infection risk

Certain features of the vaginal microbiota, including specific bacterial communities, could indicate an increased Chlamydia infection risk.

A mother’s gut microbes may influence stem cells in the next generation

Mice born to mothers exposed to Akkermansia muciniphila during pregnancy showed improvements in stem cell activity.

Specific gut metabolites may help diagnose endometriosis

The findings suggest that 4-hydroxyindole could be a promising biomarker for diagnosing endometriosis.

Microbiome’s implications in recurrent pregnancy loss

A systematic review recently published in the Journal of Reproductive Immunology provides a comprehensive overview of the emerging role of the microbiome in recurrent pregnancy loss (RPL).

Supporting women’s health through menopause: probiotic insights from IFF Health

Exploring probiotics for menopause with Maider Gutierrez, Business Development Lead for Women’s Health & Healthy Aging, IFF Health: solutions to support women's health and manage symptoms effectively.

Gut microbes may influence the risk of diabetes during pregnancy

The findings of a recent study highlight the critical role of the gut microbiota in maternal and infant health, especially in the context of GDM.

Probiotics and vaginal microbiota: clinical trial outcomes in post-menopausal women

Franco Vicariotto, Ospedale S. Pio X, Milan, talks about the results from a clinical trial in post-menopausal women.

Study identifies gut microbiota differences in polycystic ovary syndrome

The findings of a recent study suggest that the gut microbiota of women with PCOS and dyslipidemia differs from that of women with PCOS only and healthy women.

How gut bacteria may impact a woman’s health

The findings of a recent study suggest that gut bacteria transform steroids into hormones that may impact a woman’s health, especially during pregnancy.

Freya Biosciences: pioneering the development of microbial immunotherapies for women’s health

Johan van Hylckama Vlieg, CSO and Co-founder of Freya Biosciences, discusses the latest advancements in microbial immunotherapies for women's health.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top